Correlation Between Mineralys Therapeutics, and Scisparc
Can any of the company-specific risk be diversified away by investing in both Mineralys Therapeutics, and Scisparc at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mineralys Therapeutics, and Scisparc into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mineralys Therapeutics, Common and Scisparc, you can compare the effects of market volatilities on Mineralys Therapeutics, and Scisparc and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mineralys Therapeutics, with a short position of Scisparc. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mineralys Therapeutics, and Scisparc.
Diversification Opportunities for Mineralys Therapeutics, and Scisparc
-0.57 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Mineralys and Scisparc is -0.57. Overlapping area represents the amount of risk that can be diversified away by holding Mineralys Therapeutics, Common and Scisparc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Scisparc and Mineralys Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mineralys Therapeutics, Common are associated (or correlated) with Scisparc. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Scisparc has no effect on the direction of Mineralys Therapeutics, i.e., Mineralys Therapeutics, and Scisparc go up and down completely randomly.
Pair Corralation between Mineralys Therapeutics, and Scisparc
Given the investment horizon of 90 days Mineralys Therapeutics, Common is expected to generate 0.35 times more return on investment than Scisparc. However, Mineralys Therapeutics, Common is 2.88 times less risky than Scisparc. It trades about 0.01 of its potential returns per unit of risk. Scisparc is currently generating about -0.03 per unit of risk. If you would invest 1,536 in Mineralys Therapeutics, Common on August 24, 2024 and sell it today you would lose (287.00) from holding Mineralys Therapeutics, Common or give up 18.68% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Mineralys Therapeutics, Common vs. Scisparc
Performance |
| Timeline |
| Mineralys Therapeutics, |
| Scisparc |
Mineralys Therapeutics, and Scisparc Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Mineralys Therapeutics, and Scisparc
The main advantage of trading using opposite Mineralys Therapeutics, and Scisparc positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mineralys Therapeutics, position performs unexpectedly, Scisparc can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Scisparc will offset losses from the drop in Scisparc's long position.| Mineralys Therapeutics, vs. Integrated Drilling Equipment | Mineralys Therapeutics, vs. Xponential Fitness | Mineralys Therapeutics, vs. Lipocine | Mineralys Therapeutics, vs. Delek Drilling |
| Scisparc vs. Virax Biolabs Group | Scisparc vs. ZyVersa Therapeutics | Scisparc vs. Unicycive Therapeutics | Scisparc vs. Quoin Pharmaceuticals Ltd |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Complementary Tools
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |